Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection

Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection Publisher Pubmed

Azizmohammadi S¹ ; Safari A² ; Kaghazian M³ ; Sadrkhanlo M⁴ ; Yahaghi E⁵ ; Farshgar R⁶ ; Seifoleslami M⁷

Show Affiliations

1. Department of Gynecology, Hajar Hospital, AJA University of Medical Sciences, Tehran, Iran
2. Department of Gynecology, Imam Reza Hospital, AJA University of Medical Sciences, Tehran, Iran
3. Department of Biology, Jundishapur University of Medical Sciences, Ahvaz, Iran
4. Department of Obstetrics and Gynecology, Tehran University of Medical Sciences, Tehran, Iran
5. Department of Molecular Biology, Baqiyatallah University of Medical Sciences, Tehran, Iran
6. Veterinarian in Private Sector, AJA University of Medical Sciences, Tehran, Iran
7. Department of Gynecology, Khanevadeh Hospital, AJA University of Medical Sciences, Tehran, Iran

Source: QJM: An International Journal of Medicine Published:2017

Abstract

Background: MicroRNAs (miRNAs) may act as carcinogen or tumor suppressor genes by targeting various biological molecules. Therefore, it is important to identify significant markers for prognosis, diagnosis treatment strategies of cancers. Objective: To evaluate the clinical importance and prognostic value of miR-9 and miR-145 in cervical cancer. Method: miRNAs expression was detected using quantitative real-time polymerase chain reaction in cervical cancer specimens and adjacent normal tissues. Results: MiR-9 up-regulated in cervical cancer specimens than adjacent normal tissues (9.74362.172 vs. 2.13161.083; P < 0.05). MiR-145 was decreased in cervical cancer specimens compared to corresponding normal tissues (2.18960. 724 vs. 7.17361.558 P < 0.05). In addition, increased expression of miR-9 was strongly linked to lymph node metastasis (P =0.017) and vascular invasion (P =0.011). On the other hand, the low expression of miR-145 was related to advanced FIGO stage (P =0.007), lymph node metastasis (P =0.02) and vascular invasion (0.026). Kaplan-Meier survival and log-rank analysis suggested that patients with high expression of miR-9 had shorter overall survival compared with those with low expression (log-rank test P =0.028; P < 0.001). In addition, shorter overall survival time was remarkably linked to decreased expression of miR-145 (log-rank test P < 0.001). Multivariate Cox proportional hazards model analysis of miR-9 and miR-145 showed that FIGO stage (P =0.011) high expression of miR-9 and low expression of miR-145 (P=0.023; P =0.031) were independent prognostic factors for overall survival of patients. Conclusions: miRNA-145 and 9 may be as potential prognostic marker in patients suffering from cervical cancer. © The Author 2016.

Related Docs

View other Related Docs

1. Down-Expression of Mirna-98 and Over-Expression of Mirna-9 Can Result in Inadequate Immune System Response Against Lung Cancer, Biointerface Research in Applied Chemistry (2021)

2. Emerging Molecular Functions of Microrna-9: Cancer Pathology and Therapeutic Implications, Anti-Cancer Agents in Medicinal Chemistry (2021)

3. Micrornas As Biomarkers for Early Diagnosis, Targeting and Prognosis of Prostate Cancer, Pathology Research and Practice (2023)

4. Reciprocal Interconnection of Mirnome-Epigenome in Cancer Pathogenesis and Its Therapeutic Potential, Epigenetics Territory and Cancer (2015)

5. The Impact of Mir-9 Regulation in Normal and Malignant Hematopoiesis, Oncology Reviews (2018)

6. Serum and Tissue Mirnas: Potential Biomarkers for the Diagnosis of Cervical Cancer, Virology Journal (2019)

7. Inflammation Related Mirnas As an Important Player Between Obesity and Cancers, Journal of Diabetes and Metabolic Disorders (2019)

8. High-Level Expression of Ripk4 and Ezh2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer, Oncology Research (2017)

Experts (# of related papers)

View all Related Experts

Shirin Hasani-Ranjbar (1)

Naghmeh Bahrami (1)

Style	Citing Format
MLA	Azizmohammadi S, et al.. "Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection." QJM: An International Journal of Medicine, vol. 110, no. 1, 2017, pp. 11-15.
APA	Azizmohammadi S, Safari A, Kaghazian M, Sadrkhanlo M, Yahaghi E, Farshgar R, Seifoleslami M (2017). Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection. QJM: An International Journal of Medicine, 110(1), 11-15.
Chicago	Azizmohammadi S, Safari A, Kaghazian M, Sadrkhanlo M, Yahaghi E, Farshgar R, Seifoleslami M. "Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection." QJM: An International Journal of Medicine 110, no. 1 (2017): 11-15.
Harvard	Azizmohammadi S et al. (2017) 'Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection', QJM: An International Journal of Medicine, 110(1), pp. 11-15.
Vancouver	Azizmohammadi S, Safari A, Kaghazian M, Sadrkhanlo M, Yahaghi E, Farshgar R, et al.. Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection. QJM: An International Journal of Medicine. 2017;110(1):11-15.
BibTex	@article{ author = {Azizmohammadi S and Safari A and Kaghazian M and Sadrkhanlo M and Yahaghi E and Farshgar R and Seifoleslami M}, title = {Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection}, journal = {QJM: An International Journal of Medicine}, volume = {110}, number = {1}, pages = {11-15}, year = {2017} }
RIS	TY - JOUR AU - Azizmohammadi S AU - Safari A AU - Kaghazian M AU - Sadrkhanlo M AU - Yahaghi E AU - Farshgar R AU - Seifoleslami M TI - Molecular Identification of Mir-145 and Mir-9 Expression Level As Prognostic Biomarkers for Early-Stage Cervical Cancer Detection JO - QJM: An International Journal of Medicine VL - 110 IS - 1 SP - 11 EP - 15 PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract